Burnout may lead family doctors to leave medicine

Family physicians who report feeling burned out are nearly 1.5 times more likely to change practices or stop practicing medicine entirely than their peers who don’t report burnout.

Cornell Tech partners with Mastercard to advance AI governance standards

Cornell Tech has launched a research collaboration with Mastercard to advance methods for evaluating and auditing generative artificial intelligence systems, in an effort to maximize their benefits.

Weill Cornell Medicine’s Class of 2026 learns next step on Match Day

The class of 2026 learned on March 20 where they will be doing their internship and residency training, setting the stage for the next several years of their medical careers and lives.

AI tools show promise for diagnosing advanced heart failure

The study offers the prospect of better care for many thousands of patients who may be overlooked due to the difficulty of diagnosing their condition.

Students pitch AI-inspired solutions at Cornell Health Hackathon

More than 100 students from across Cornell campuses and 17 other universities gathered March 6-8 in New York City for an AI hackathon.

Unusual tumor cells may be overlooked factors in advanced breast cancer

A circulating tumor cell called a dual-positive cell is associated with shorter survival time in patients with advanced breast cancer.

AI assistants can sway writers’ attitudes, even when they’re watching for bias

Cornell Tech researchers found that writers who used biased AI auto-suggestions saw their views gravitate toward the AI’s positions without their realizing it — even when they were made aware of the biased AI.

One flu virus can hamper the immune response to another

Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against subsequent exposure to a different flu strain.

Prior authorization bans for opioid treatment may not improve retention

State laws that ban insurance prior authorization for buprenorphine, used for opioid use disorder, may not help more patients stay in treatment for the recommended 180 days, Weill Cornell Medicine researchers report.